Recipient cells expressing single donor MHC locus products can substitute for donor-specific transfusion in the induction of transplantation tolerance when pretreatment is combined with anti-Cd4 monoclonal antibody. Evidence for a vital role of Cd4+ T cells in the induction of tolerance to class I molecules

Transplantation

Volumn 61, Issue 10, 1996, Pages 1532-1538

  Saitovitch, David ^a   Morris, Peter J ^a   Wood, Kathryn J ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; MONOCLONAL ANTIBODY;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIGEN PRESENTATION; ARTICLE; CONTROLLED STUDY; IMMUNE RESPONSE; IMMUNOLOGICAL TOLERANCE; IMMUNOMODULATION; MAJOR HISTOCOMPATIBILITY COMPLEX; MOUSE; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; ANTIBODIES, MONOCLONAL; ANTIGENS, CD4; ANTIGENS, CD8; BLOOD TRANSFUSION; CD4-POSITIVE T-LYMPHOCYTES; GENES, MHC CLASS I; GENES, MHC CLASS II; HEART TRANSPLANTATION; HISTOCOMPATIBILITY ANTIGENS CLASS I; HISTOCOMPATIBILITY ANTIGENS CLASS II; IMMUNE TOLERANCE; L CELLS (CELL LINE); MALE; MICE; MICE, INBRED BALB C; MICE, INBRED C3H; MICE, INBRED C57BL; SURVIVAL ANALYSIS; TRANSFECTION;

EID: 0029954498     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-199605270-00021     Document Type: Article

References (37)

1. Billingham RE, Brent L, Medawar PB. Actively acquired tolerance of foreign cells. Nature 1953; 172: 603.
2. Pearson TC, Madsen JC, Larsen CP, Morris PJ, Wood KJ. Induction of transplantation tolerance in adults using donor antigen and anti-CD4 monoclonal antibody. Transplantation 1992; 54: 475.
3. Vaidya S, Sommer BG, Pagel E, Koegel M, Ferguson RM. Assessment of factors associated with donor-specific sensitization in patients given donor-specific blood transfusions. Transplantation 1986; 42: 695.
4. Madsen JC, Superina RA, Wood KJ, Morris PJ. Immunological unresponsiveness induced by recipient cells transfected with donor MHC genes. Nature 1988; 332: 161.
5. Bell IL. An investigation into the induction of specific immunological unresponsiveness using donor major histocompatibility complex antigens. University of Oxford: D.Phil Thesis, 1994.
6. Qin S, Cobbold S, Tighe H, Benjamin R, Waldmann H. CD4 monoclonal antibody pairs for immunosuppression and tolerance induction. Eur J Immunol 1987; 17: 1159.
7. Cobbold SP, Jayasuria A, Nash A, Prospero TD, Waldmann H. Therapy with monoclonal antibodies by elimination of T-cell subsets in vivo. Nature 1984; 312: 548.
8. Kohler G, Fisher Lindahl K, Heusser C. Characterization of a monoclonal anti-H-2Kb antibody. Immune System 1981; 2: 202.
9. Ozato K, Sachs DH. Monoclonal antibodies to mouse MHC antigens: III. Hybridoma antibodies reacting to antigens of the H-2b haplotype reveal genetic control of isotype expression. J Immunol 1981; 126: 317.
10. Steinman RM, Nogueira N, Witmer MD, Tydings JD, Mellman IS. Lymphokine enhances the expression and synthesis of Ia antigens on cultured mouse peritoneal macrophages. J Exp Med 1980; 152: 1248.
11. Ozato K, Mayer N, Sachs DH. Hybridoma cell lines secreting monoclonal antibodies to mouse H-2 and Ia antigens. J Immunol 1980; 124: 533.
12. Corry R, Winn H, Russell P. Primarily vascularized allografts of hearts in mice: the role of H-2D, H-2K and non-H-2 antigens in rejection. Transplantation 1973; 16: 343.
13. Superina RA, Peugh WN, Wood KJ, Morris PJ. Assessment of primarily vascularized cardiac allografts in mice. Transplantation 1986; 42: 226.
14. Pearson TC, Bushell AR, Darby CR, West LJ, Morris PJ, Wood KJ. Lymphocyte changes associated with prolongation of cardiac allograft survival in adult mice using anti-CD4 monoclonal antibody. Clin Exp Immunol 1993; 92: 211.
15. Peto R, Pike P, Armitage P, et al. Design and analysis of randomized clinical trials which require prolonged observations of each patient: II Analysis and examples. Br J Cancer 1977; 35: 1.
16. Swain SL. T cell subsets and the recognition of MHC class. Immunol Rev 1983; 74: 129.
17. Shoskes DA, Wood KJ. Indirect presentation of MHC antigens in transplantation. Immunol Today 1994; 15: 32.
18. Ting A, Welsh K. HLA matching and crossmatching in renal transplantation. In Morris PJ, ed. Kidney transplantation: principles and practice, Philadelphia: Saunders, 1994: 109.
19. Sykes M, Sachs DH, Nienhuis AW, Pearson DA, Moulton AD, Bodine DM. Specific prolongation of skin graft survival following retroviral transduction of bone marrow with an allogeneic major histocompatibility complex gene. Transplantation 1993; 55: 197.
20. Sachs DH, Bodine DM, Moulton AD, Pearson DA, Nienhuis AW, Sykes M. Tolerance induction using autologous bone marrow modified with an allogeneic class I MHC gene. Transplant Proc 1993; 25: 348.
21. Knechtle SJ, Wang J, Jiao S, Geissler EK, Sumimoto R, Wolff J. Induction of specific tolerance by intrathymic injection of recipient muscle cells transfected with donor class I major histocompatibility complex. Transplantation 1994; 57: 990.
22. + T cell regulation during the induction phase. Eur J Immunol 1995; 25: 2643.
23. Qin S, Cobbold SP, Pope H, et al. Infectious transplantation tolerance. Science 1993; 259: 974.
24. Bianchi ATJ, Bril H, Benner R. Alloantigen-specific suppressor T cells can also suppress the in vivo immune response to unrelated alloantigens. Nature 1983; 301: 614.
25. Rodey GE, Neylan JF, Whelchel JD, Revels KW, Bray RA. Epitope specificity of HLA class I alloantibodies: I. Frequency analysis of antibodies to private versus public specificities in potential transplant recipients. Hum Immunol 1994; 39: 272.
26. Lechler RI, Lombardi G, Batchelor JR, Reinsmoen N, Bach FH. The molecular basis of alloreactivity. Immunol Today 1990; 11: 83.
27. Taswell C, MacDonald HR, Cerottini JC. Clonal analysis of cytolytic T lymphocyte specificity: I. phenotypically distinct sets of clones as the cellular basis of cross-reactivity to alloantigens. J Exp Med 1980; 151: 1372.
28. Lindahl KF, Wilson DB. Histocompatibility antigen-activated cytotoxic T lymphocytes: II. estimates of the frequency and specificity of precursors. J Exp Med 1977; 145: 508.
29. Tomkinson BE, Maziarz R, Sullivan JL. Characterization of the T cell-mediated cellular cytotoxicity during acute infectious mononucleosis. J Immunol 1989; 143: 660.
30. Shendel DJ, Reinhardt C, Nelson PJ, et al. Cytotoxic T lymphocytes show HLA-C-restricted recognition of EBV-bearing cells and allorecognition of HLA class I molecules presenting self peptides. J Immunol 1992; 149: 2406.
31. Burrows SR, Khanna R, Burrows JM, Moss DJ. An alloresponse in humans is dominated by cytotoxic T lymphocytes (CTL) cross-reactive with a single epstein-barr virus CTL epitope: implications for graft-versus-host disease. J Exp Med 1994; 179: 1155.
32. Nahill SR, Welsh RM. High frequency of cross-reactive cytotoxic T lymphocytes elicited during the virus-induced polyclonal cytotoxic T lymphocyte response. J Exp Med 1993; 177: 317.
33. Kapasi K, Chui B, Inman RD. HLA-B27/microbial mimicry: an in vivo analysis. Immunology 1992; 77: 456.
34. Norman DJ, Bennett WM, Cobanoglu A, et al. Use of OKT4A (a murine monoclonal anti-CD4 antibody) in human organ transplantation: initial clinical experience. Transplant Proc 1993; 25: 802.
35. Henell KR, Cheever JM, Kimball JA, et al. OKT4A (a murine IgG2a anti-CD4 monoclonal antibody) in human organ transplantation: pharmacokinetics and peripheral pharmacodynamics. Transplant Proc 1993; 25: 800.
36. Meiser BM, Reiter C, Reichenspurner H, et al. Chimeric monoclonal CD4 antibody - a novel immunosuppressant for clinical heart transplantation. Transplantation 1994; 58: 419.
37. Saitovitch D, Bushell AR, Morris PJ, Wood KJ. Induction of transplantation tolerance using a nondepleting anti-CD4 mAb and donor specific transfusion before transplantation: evidence that a critical period of time is required for the development of immunological unresponsiveness. Transplant Proc 1995; 27: 117.